FDA EUA given to some of the rapid LFIAs are even revoked due to low accuracy and false-negative results such as Autobio Diagnostics Co., Ltd.’s Anti-SARS-CoV-2 Rapid Test and Chembio Diagnostic Systems, Inc.’s DPP COVID-19 IgM/IgG System. The gene discussed is CD40LG; the disease is COVID-19.